Skip Navigation

Frank Gerberick Receives Award for Advancing Alternatives

November 24, 2014
Alternatives Research & Development Foundation

Frank Gerberick, a scientist at the Procter & Gamble Company, based in Cincinnati, Ohio, received the William and Eleanor Cave Award last week at a private reception in Bethesda, Maryland.

The Award was presented by the Alternatives Research & Development Foundation (ARDF) of Jenkintown, Pennsylvania, before a gathering of dozens of colleagues at the third Annual Meeting of the American Society for Cellular and Computational Toxicology (ASCCT).

ARDF President Sue Leary explained, “This recognition is for Frank Gerberick’s impressive career achievements in developing alternative test methods. He has been a real leader in the field.” Dr. Gerberick began his alternatives research in late 1980s, and in January 2014, European authorities accepted the Direct Peptide Reactivity Assay (DPRA), an alternative test method his team developed for skin sensitization. Over the years, he has been an author on over 160 scientific articles, and received numerous awards and honors for his work, including the Society of Toxicology’s Animal Welfare Award.

See full details here.

New ALTEX: 2/2018

ALTEX cover 51
 

Support ALTWEB, Make a Gift
Online Humane Science Course

MeetingS

 
Building a Better Epithelium: New Frontiers in 3D Conference
April 25, 2019
Cambridge, MA

CellTox 2019
May 7, 2019
Milano, Italy

Biosystems Engineering: Bioreactors and Cell Factories
May 12-17, 2019
Braunweld, Switzerland

ALTERTOX Academy Training:
In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhalation Toxicology
May 23-24, 2019
Neuchatel, Switzerland

6th Symposium on Social Housing of Laboratory Animals
June 3-4, 2019
Beltsville, Maryland

Society for In Vitro Biology Annual Meeting
June 8-12, 2019
Tampa, Florida

Upcoming: CAAT-Europe Information Day On Biology-inspired Microphysiological Systems (MPS) to Advance Medicines for Patients' Benefit
June 17, 2019
Berlin, Germany

ALTERTOX Academy Training:
PBPK Modeling and Quantitative In Vitro-In Vivo Extrapolation
October 3-4, 2019
Wageningen, Netherlands

ALTERTOX Academy Training:
Novel In Silico Models for Assessment of Cosmetics
October 17-18, 2019
Milan, Italy

ALTERTOX Academy Training:
In Vitro Lung Models
November 14-15, 2019
Geneva, Switzerland

Save the Date!
5th International Conference on Alternatives for Developmental Neurotoxicity (DNT) Testing
February 3-5, 2020
Konstanz, Germany

Full Listing of CAAT Programs
and Activities